Kobayashi Pharmaceutical Balance Sheet Health
Financial Health criteria checks 6/6
Kobayashi Pharmaceutical has a total shareholder equity of ¥205.0B and total debt of ¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ¥261.3B and ¥56.3B respectively. Kobayashi Pharmaceutical's EBIT is ¥25.6B making its interest coverage ratio -34.4. It has cash and short-term investments of ¥70.7B.
Key information
0%
Debt to equity ratio
JP¥0
Debt
Interest coverage ratio | -34.4x |
Cash | JP¥70.71b |
Equity | JP¥204.97b |
Total liabilities | JP¥56.29b |
Total assets | JP¥261.25b |
Recent financial health updates
No updates
Recent updates
Getting In Cheap On Kobayashi Pharmaceutical Co., Ltd. (TSE:4967) Is Unlikely
Aug 04Investor Optimism Abounds Kobayashi Pharmaceutical Co., Ltd. (TSE:4967) But Growth Is Lacking
Apr 21Estimating The Fair Value Of Kobayashi Pharmaceutical Co., Ltd. (TSE:4967)
Apr 03Investors Met With Slowing Returns on Capital At Kobayashi Pharmaceutical (TSE:4967)
Feb 27Financial Position Analysis
Short Term Liabilities: 4967's short term assets (¥138.4B) exceed its short term liabilities (¥51.0B).
Long Term Liabilities: 4967's short term assets (¥138.4B) exceed its long term liabilities (¥5.3B).
Debt to Equity History and Analysis
Debt Level: 4967 is debt free.
Reducing Debt: 4967 has no debt compared to 5 years ago when its debt to equity ratio was 0.3%.
Debt Coverage: 4967 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 4967 has no debt, therefore coverage of interest payments is not a concern.